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ABSTRACT
Currently, therapy with Platelet Rich Plasma (PRP) has been widely used and continues to grow for various clinical applications. 
Along with its development, there are various options in the method of obtaining PRP, either automatic or manual, while one of the 
most reliable methods according to the literature is a double centrifugation method. The purpose of this research is to produce an 
optimization of the double centrifugation method. This study used experimental data obtained by conducting a research at the Clinical 
Pathology Laboratory of Dr. Soetomo Hospital, Surabaya. Experiments were conducted on stored blood obtained from the blood bag 
from Indonesian Red Crossand fresh blood from healthy donors with CPD anticoagulant. Results: PRP with optimum platelet count 
could be made with sufficient personal laboratory skills and amounted to 4.11 times with the platelet count of 1.152 million using 1300 
rcf for 5 minutes for the first centrifugation, and 2300 rcf for 7 minutes for the second centrifugation.
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ABSTRAK
Latar Belakang: Saat ini terapi dengan menggunakan Platelet Rich Plasma (PRP) telah banyak digunakan dan menjadi pilihan 
dalam dunia klinis. Adapun dalam perkembangannya terdapat beberapa pilihan metode, baik secara otomatis maupun manual, meskipun 
metode yang paling dipercaya adalah metode double centrifugation. Tujuan: Untuk menemukan optimalisasi yang paling tepat untuk 
metode tersebut. Penelitian ini menggunakan data eksperimental yang dilakukan oleh peneliti dari Laboratorium Patologi Klinik 
RSUD Dr. Soetomo Surabaya. Metode: Penelitian ini menggunakan plasma darah yang diperoleh dari Palang Merah, yang berasal 
dari donor dengan CPD anticoagulant. Hasil: PRP dengan perhitungan platelet optimum ditunjang dengan kemampuan laboratorium 
dapat dicapai hingga 4.11 kali dengan perhitungan 1.152 million, menggunakan 1300 rcf selama 5 menit pada putaran pertama dan 
2300 rcf selama 7 menit pada putaran kedua.
Kata kunci: Platelet Rich Plasma, Double Centrifugation Method, Stem Cell Therapy
Research Report
INTRODUCTION
As a relatively new subject, stem cells can be said to 
have tremendous potential, starting early in life and growing 
up as a sort of internal improvement system, proliferate and 
differentiate without definite limits to later form the other 
cells as long as the relevant person or animal is still alive . 
As one of the internal improvement system, the proliferation 
of stem cells can be stimulated in the presence of growth 
factors. Growth factors are found in PRP (Platelet Rich 
Plasma) in large numbers.
In Indonesia, the current stem cell therapy is a field 
that currently emerged, and still not a lot of work of which 
the method is widely used and applicable. PRP was highly 
rated in terms of potential for use as a treatment of chronic 
tendinitis, wound healing, regeneration of cartilage or discs, 
as well as cardiac applications.
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There are various methods used for the manufacture of 
this PRP, from sophisticated which can only be performed 
at hospitals using apheresis devices, up to a practical 
method that can be performed directly in clinics. From 
variously different methods and protocols, there are still no 
research in Indonesia on what the most optimal method is. 
Therefore, it is felt that there is a need to have a research 
and optimization on double centrifugation method. The 
method, according to the literature, is the most reliable one 
and relatively simple. So as to produce a protocol that PRP 
produces reliable and proven quality.
MATERIALS AND METHODS
This is a laboratory experiment which is intended to 
get the most reliable PRP making method with platelet 
count as the indicator. The materials and tools were sterile 
tubes, syringes, sterile long needle, CPD anticoagulant, 
centrifuge, and Sysmex automatic hematology analyzer. 
The experiment was conducted in the laboratory of 
clinical pathology department of Dr. Soetomo Hospital, 
Surabaya.
Sample Collection
The blood samples were obtained from a blood bag 
from a donor, and also from fresh blood from other donors. 
To get as much as 1 ml of PRP, we took blood samples of 
10 ml with 9:1 CPD anticoagulant. For the optimization 
experiment of centrifugation phase and separation phase, 
we performed 30 tests, hence the total experiment required 
a sample size of 300 ml of blood.
PRP Isolation
Platelet count was conducted twice for a sample, one 
before, and another after the optimization process. The 
optimization process itself was a series of variation on 
velocity and time of centrifugation, twice on each sample. 
It varied from 200 to 2300 rcf, and 5 to 15 minutes on each 
centrifugation.
Separations were manually done with ± 1 mm of margin 
after each centrifugation, in order to purify as much as 
possible, the result was extracted from erythrocytes and 
Platelet Poor Plasma (PPP). The visible buffy coat from the 
first separation was essential to be maintained until the end 
of the optimization process. The first separation was done 
in order to separate erythrocytes as much as possible, while 
Table 1. Platelet count result
Sample 
No.
1st Centrifugation 2nd Centrifugation Platelet Count 1 
(x 103/μl)
Platelet Count 2 
(x 103/μl)
Rise
Force (rcf) Time (min.) Force (rcf) Time (min.)
001 1200 5 2000 6 92 271 2.94 x
002 200 15 1500 15 87 194 2.23 x
003 300 10 1500 15 87 65 0.74 x
004 600 5 1500 15 87 106 1.22 x
005 900 5 1500 15 87 129 1.48 x
006 1200 5 1500 15 87 33 0.38 x
007 1500 5 1500 15 87 41 0.47 x
008 200 15 2000 6 87 90 1.03 x
009 300 10 2000 6 87 47 0.54 x
010 600 5 2000 6 87 23 0.26 x
011 900 5 2000 6 87 31 0.36 x
012 1200 5 2000 6 87 37 0.43 x
013 1500 5 2000 6 87 33 0.38 x
014 200 15 1500 15 170 62 0.37 x
015 200 15  600 15 104 109 1.05 x
016 600 30 1500 10 104 29 0.28 x
017 1300 5 2300 7 280 1152 4.11 x
018 900 5 2300 7 104 37 0.36 x
019 1300 5 2300 7 104 22 0.21 x
020 1200 5 2000 6 239 181 0.76 x
021 1300 5 2300 7 239 428 1.79 x
022 600 5 2000 6 234 140 0.59 x
023 1300 5 2300 7 234 186 0.79 x
024 600 5 2000 6 228 288 1.26 x
025 900 5 1500 15 228 292 1.28 x
026 1200 5 2000 6 228 431 1.89 x
027 1300 5 2300 7 228 898 3.94 x
028 600 5 2000 6 183 469 2.56 x
029 1200 5 2000 6 205 269 1.31 x
030 1300 5 2300 7 251 327 1.30 x
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the second was to separate PPP leaving the bottom with 
1 ml of liquid, which was considered to be the PRP.
Each set of variation was repeated at least 2 times to 
assure the reliability of the current method. The resulting 
data were analyzed by using simple analytical statistics. The 
thrombocyte count of the PRP obtained was measured by 
automated Sysmex XE-2100 Hematology Analyzer which 
had a unique fluorescent flow cytometry and hydrodynamic 
focusing technologies to minimize the review rates and 
produce accurate results even when interferences or artifacts 
were present.1 Hence, the result presented in this study was 
made to be as accurate as possible, with very less likely to 
be false positive.
RESULTS AND DISCUSSION
Experiments of optimization of double centrifugation 
method in platelet rich plasma gave the following result:
Due to the limited budget towards the experiment, 
a PDGF BB test was performed only as an additional 
infromation, based on the highest result produced by the 
protocol, to ensure that it would still be a useful PRP after 
processed through the protocol. The result proved that it 
was still a useful PRP with PDGF BB 3401 pg/ml after 
processing through this protocol. This amount could still 
increase after activation, which was not included and tested 
further in this current preliminary study due to some fund 
limitation. But, as defined by Textor, the conventional 
human definition of PRP is plasma containing resting 
platelets at a concentration of at least 106/ul. The PRP may 
or may not be activated prior to use, hence the term “PRP” 
does not indicate that activation has occurred.2 Alone, 
platelet count itself is considered to be one of the key factors 
used to standardize research studies for the regenerative 
capacity of PRP. Maximum platelet concentration of PRP 
with manual double centrifugation method by Kakudo is 
7.9 x.3 Too, qualitative changes in the platelet may also 
affect the regenerative potential of PRP. According to 
Marx, a damaged or nonviable platelet will not release 
bioactive growth factors, thus the resulting PRP may be 
disappointing. The PRP for clinical treatment should be 
sought about 1,000,000 platelets per microliter. Given 
that whole blood contains approximately 200,000 ± 75 
000 platelets per microliter, then the therapeutic PRP must 
have an average percentage of increase of about 400% in 
platelet count.4 Therefore, this experiment indicates that the 
optimum result from this experiment might be a standard 
for PRP making.
But as we can see in table 1, there were quite significant 
inconsistencies in the correlation between force and time of 
centrifugation to increase the platelet count after the double 
centrifugation method in PRP making. It seemed that it 
was very dependent on the fidelity of manual separation 
processes between the centrifugations. The later samples 
results were higher than the early ones since the researchers 
become more accustomed and skilled in the manual 
separation process. Errors might also be found because of 
the absence of PRP resuspension before the platelet was 
counted by the analyst. Resuspension could be important 
because there were trapped platelets in the buffy coat, so 
resuspension will show the tangible number of platelets in 
PRP.5 Hence, it could be concluded that the factor of trained 
person in the whole process might be more significantly 
important rather than the centrifugation process itself. This 
might also explain the very wide spectrum and range in 
protocol in centrifugation force and time to this day, which 
ranges from 72 G for 15 minutes, 160 G for 20 minutes, 250 
G for 10 minutes, 900 G for 5 min, 1300 G for 10 minutes, 
up to 1400 G for 4 minutes, for the first centrifugation. The 
second centrifugation itself has a variable speed from 400 G 
to 2000 G, and has a variable period of time from 6 minutes 
to 15 minutes. Similarly, with temperatures varying from 
4° C, 15° C, up to room temperature.5,6,7,8,9
Anticoagulant Acid Citrate Dextrose (ACD) type A 
and low-speed centrifugation can be used to maintain the 
integrity of the platelet membrane.5 But according to the 
study of Shimizu et al, PRP is created with the anticoagulant 
Citrate Phosphate Dextrose (CPD) had a 4% higher platelet 
count when using 5 ml of full blood, and 4.5% higher using 
200 ml of full blood.10 Hence, this experiment used CPD 
anticoagulant instead of ACD.
Overall, the highest increment in platelet count 
was obtained using 1300 rcf for 5 minutes for the first 
centrifugation, and 2300 rcf for 7 minutes for the second 
centrifugation as we can see in samples 017 and 027. This 
is quite different with the finding of Jo CH and colleagues 
from orthopedic surgery department of Seoul National 
University Boramae Hospital, which stated that the platelet 
count would be optimum with double centrifugation method 
with the use of 900 G in the first centrifugation for 5 min 
and 1500 Gin the second centrifugation for 15 minutes.9
Besides the double centrifugation method, there are 
already several automated methods developed independently 
by many institutions. Among these methods are Curasan 
PRP Kit by Curasan, Kleinostheim, Germany; method 
PCCS PRP System by 3i Implant Innovations, Palm Beach 
Gardens, Florida, United States; and methods SmartPrep 
by Harvest Technologies, Plymouth, Massachusetts 
United States. However, research by Castillo showed no 
significant differences in the platelet concentration, in the 
number of erythrocytes, the TGFβ1, or in the fibrinogen 
levels between the various automated methods.11 And since 
there was no availability of any automated PRP machines 
in both the Medical Faculty Universitas Airlangga and Dr. 
Soetomo Hospital Surabaya, there was no difference in the 
method used in this experiment. But, based on Kurita et al 
experiment in 2008, double centrifugation method itself 
was described as the most accurate and rational choice for 
manual making experiment of PRP, conformed by Nagata 
in 2010, since it produced more platelets and more active 
substances.7,12 Castillo also suggests that the usage of 
method and protocol should be based on associated rational 
choice instead of trying tremendous variability available 
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by automated machines which are described as “the jungle 
world of commercial proposals and products”.
As the concentrated platelet, PRP rich in basic growth 
factors and has potential various clinical applications with 
no virtual risks. To initiate the process of wound healing, 
there are Platelet Derived Growth Factor (PDGFαα, 
PDGFββ, PDGFαβ), Transforming Growth Factors-β 
(TGF-β1 and TGF-β2), Vascular Endothelial Growth Factor 
(VEGF), Epithelial Growth Factor (EGF). In addition 
PRP also contains adhesion molecules necessary for 
bone grafting and the matrix of bone, such as osteocalcin, 
osteonectin, and bone morphogenic protein (BMP) -2 
and BMP-4.4,13 Platelets also have a Platelet Factor 4 
(PF4), interleukin (IL) -1, Platelet-Derived Angiogenesis 
Factor (PDAF), Platelet-Derived Endothelial Growth 
Factor (PDEGF), Epithelial Cell Growth Factor (ECGF), 
Insulin-Like growth Factor (IGF), vitronectin, fibrinogen, 
fibronectin, and thrombospondin (TSP) -1.14,15,16 PRP also 
shows some potential for treatment of myocardial infarction 
in experiments using the musmusculus.17 In addition to 
the usefulness above, PRP is also potentially used in 
a variety of other clinical applications such as muscle 
healing,18 peripheral nerve damages,19 and maxillofacial 
surgeries.20
Suggestions
This project is a preliminary study about the manual 
making of for PRP and therefore its goal is to obtain a 
standard protocol to make PRP according to the present 
definition. For further study such as therapeutic effect 
and usage safety, further investigation is encouraged by 
using both experimental and clinical trials to follow up the 
therapeutic effects of the PRP in tissues or animal models 
by investigating the growth factors and the regeneration 
process from time to time there. 
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